230 related articles for article (PubMed ID: 24836181)
1. The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice.
Liu Y; Liang Y; Hou B; Liu M; Yang X; Liu C; Zhang J; Zhang W; Ma Z; Gu X
Pharmacol Biochem Behav; 2014 Sep; 124():19-26. PubMed ID: 24836181
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal injection of selected peptide Myr-RC-13 attenuates bone cancer pain by inhibiting KIF17 and NR2B expression.
Ni K; Zhou Y; Sun YE; Liu Y; Gu XP; Ma ZL
Pharmacol Biochem Behav; 2014 Jul; 122():228-33. PubMed ID: 24726705
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
4. Kinesin superfamily protein 17 contributes to the development of bone cancer pain by participating in NR2B transport in the spinal cord of mice.
Liu M; Liu Y; Hou B; Bu D; Shi L; Gu X; Ma Z
Oncol Rep; 2015 Mar; 33(3):1365-71. PubMed ID: 25573412
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA.
Zhang R; Liu Y; Zhang J; Zheng Y; Gu X; Ma Z
Pharmacol Biochem Behav; 2012 Jul; 102(1):139-45. PubMed ID: 22503970
[TBL] [Abstract][Full Text] [Related]
6. Reversal of chronic inflammatory pain by acute inhibition of Ca2+/calmodulin-dependent protein kinase II.
Luo F; Yang C; Chen Y; Shukla P; Tang L; Wang LX; Wang ZJ
J Pharmacol Exp Ther; 2008 Apr; 325(1):267-75. PubMed ID: 18178903
[TBL] [Abstract][Full Text] [Related]
7. CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice.
Liang Y; Liu Y; Hou B; Zhang W; Liu M; Sun YE; Ma Z; Gu X
Mol Pain; 2016; 12():. PubMed ID: 27060162
[TBL] [Abstract][Full Text] [Related]
8. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F
Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal injection of KN93 attenuates paradoxical remifentanil-induced postoperative hyperalgesia by inhibiting spinal CaMKII phosphorylation in rats.
Jiang M; Zhang W; Cheng C; Ma Z; Gu X
Pharmacol Biochem Behav; 2015 Jul; 134():35-41. PubMed ID: 25937575
[TBL] [Abstract][Full Text] [Related]
10. Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice.
Qi F; Liu T; Zhang X; Gao X; Li Z; Chen L; Lin C; Wang L; Wang ZJ; Tang H; Chen Z
Neuropharmacology; 2020 Jan; 162():107783. PubMed ID: 31541650
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of REST on NR2B in spinal cord contributes to the development of bone cancer pain in mice.
Wang D; Yu J
Oncotarget; 2016 Dec; 7(51):85564-85572. PubMed ID: 27732941
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.
Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
[TBL] [Abstract][Full Text] [Related]
13. Molecular motor KIF17 is fundamental for memory and learning via differential support of synaptic NR2A/2B levels.
Yin X; Takei Y; Kido MA; Hirokawa N
Neuron; 2011 Apr; 70(2):310-25. PubMed ID: 21521616
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of spinal dorsal horn neuron NMDA receptor phosphorylation as the mechanism of remifentanil induced hyperalgesia: Roles of PKC and CaMKII.
Li S; Zeng J; Wan X; Yao Y; Zhao N; Yu Y; Yu C; Xia Z
Mol Pain; 2017; 13():1744806917723789. PubMed ID: 28714352
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal inhibition of calcium/calmodulin-dependent protein kinase II in diabetic neuropathy adversely affects pain-related behavior.
Jelicic Kadic A; Boric M; Ferhatovic L; Banozic A; Sapunar D; Puljak L
Neurosci Lett; 2013 Oct; 554():126-30. PubMed ID: 24035897
[TBL] [Abstract][Full Text] [Related]
16. Perturbing NR2B-PSD-95 interaction relieves neuropathic pain by inactivating CaMKII-CREB signaling.
Xu F; Zhao X; Liu L; Song J; Zhu Y; Chu S; Shao X; Li X; Ma Z; Gu X
Neuroreport; 2017 Sep; 28(13):856-863. PubMed ID: 28746067
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
[TBL] [Abstract][Full Text] [Related]
18. Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain.
Katano T; Nakazawa T; Nakatsuka T; Watanabe M; Yamamoto T; Ito S
Neuropharmacology; 2011 Mar; 60(4):609-16. PubMed ID: 21167847
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Ca2+/calmodulin-dependent protein kinase II catalysis by N-methyl-D-aspartate receptor subunit 2B.
Pradeep KK; Cheriyan J; Suma Priya SD; Rajeevkumar R; Mayadevi M; Praseeda M; Omkumar RV
Biochem J; 2009 Apr; 419(1):123-32, 4 p following 132. PubMed ID: 19086921
[TBL] [Abstract][Full Text] [Related]
20. α(2) noradrenergic receptor suppressed CaMKII signaling in spinal dorsal horn of mice with inflammatory pain.
Wang XT; Lian X; Xu YM; Suo ZW; Yang X; Hu XD
Eur J Pharmacol; 2014 Feb; 724():16-23. PubMed ID: 24374198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]